Trial Profile
Single Center, Open-label, Randomized, Controlled, Cross Over Study to Evaluate the Pharmacokinetic and Bioavailability of Envarsus® in Comparison to Advagraf® in de Novo Liver Transplant Recipients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 May 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Pharmacokinetics
- 02 May 2019 Status changed from recruiting to completed.
- 05 Mar 2016 New trial record